BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reiter E, Ayoub MA, Pellissier LP, Landomiel F, Musnier A, Tréfier A, Gandia J, De Pascali F, Tahir S, Yvinec R, Bruneau G, Poupon A, Crépieux P. β-arrestin signalling and bias in hormone-responsive GPCRs. Mol Cell Endocrinol 2017;449:28-41. [PMID: 28174117 DOI: 10.1016/j.mce.2017.01.052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 McGlone ER, Ansell TB, Dunsterville C, Song W, Carling D, Tomas A, Bloom SR, Sansom MSP, Tan T, Jones B. Hepatocyte cholesterol content modulates glucagon receptor signalling. Mol Metab 2022;:101530. [PMID: 35718339 DOI: 10.1016/j.molmet.2022.101530] [Reference Citation Analysis]
2 Chen H, Zhang S, Zhang X, Liu H. QR code model: a new possibility for GPCR phosphorylation recognition. Cell Commun Signal 2022;20:23. [PMID: 35236365 DOI: 10.1186/s12964-022-00832-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zamolodchikova TS, Tolpygo SM, Kotov AV. From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior. Front Pharmacol 2021;12:772217. [PMID: 34803713 DOI: 10.3389/fphar.2021.772217] [Reference Citation Analysis]
4 Zariñán T, Mayorga J, Jardón-Valadez E, Gutiérrez-Sagal R, Maravillas-Montero JL, Mejía-Domínguez NR, Martínez-Luis I, Yacini-Torres OG, Cravioto MD, Reiter E, Ulloa-Aguirre A. A Novel Mutation in the FSH Receptor (I423T) Affecting Receptor Activation and Leading to Primary Ovarian Failure. J Clin Endocrinol Metab 2021;106:e534-50. [PMID: 33119067 DOI: 10.1210/clinem/dgaa782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest 2021. [PMID: 34417736 DOI: 10.1007/s40618-021-01663-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 McGlone ER, Manchanda Y, Jones B, Pickford P, Inoue A, Carling D, Bloom SR, Tan T, Tomas A. Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling. Mol Metab 2021;53:101296. [PMID: 34271220 DOI: 10.1016/j.molmet.2021.101296] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Casarini L, Simoni M. Recent advances in understanding gonadotropin signaling. Fac Rev 2021;10:41. [PMID: 34046645 DOI: 10.12703/r/10-41] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
8 Yun Y, Ji J, Lee HH. Dissecting the structural features of β-arrestins as multifunctional proteins. Biochim Biophys Acta Proteins Proteom 2021;1869:140603. [PMID: 33421644 DOI: 10.1016/j.bbapap.2021.140603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Krause G, Eckstein A, Schülein R. Modulating TSH Receptor Signaling for Therapeutic Benefit. Eur Thyroid J 2020;9:66-77. [PMID: 33511087 DOI: 10.1159/000511871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhu J, Sun T, Zhang J, Liu Y, Wang D, Zhu H, Yao H, Ding J, Hu G, Lu M. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson’s disease model via a β-arrestin2-biased mechanism. Brain, Behavior, and Immunity 2020;90:259-71. [DOI: 10.1016/j.bbi.2020.08.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Casarini L, Riccetti L, Paradiso E, Benevelli R, Lazzaretti C, Sperduti S, Melli B, Tagliavini S, Varani M, Trenti T, Morini D, Falbo A, Villani MT, Jonas KC, Simoni M. Two human menopausal gonadotrophin (hMG) preparations display different early signaling in vitro. Mol Hum Reprod 2020;26:894-905. [PMID: 33084890 DOI: 10.1093/molehr/gaaa070] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Yang LK, Hou ZS, Tao YX. Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases. Biochim Biophys Acta Mol Basis Dis 2021;1867:165973. [PMID: 32949766 DOI: 10.1016/j.bbadis.2020.165973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
13 Al-Sabah S, Adi L, Bünemann M, Krasel C. The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor. Front Pharmacol 2020;11:1271. [PMID: 32903502 DOI: 10.3389/fphar.2020.01271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM, Wang MW, Wootten D. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors. Biochem Pharmacol 2020;177:114001. [PMID: 32360365 DOI: 10.1016/j.bcp.2020.114001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
15 Zariñán T, Butnev VY, Gutiérrez-Sagal R, Maravillas-Montero JL, Martínez-Luis I, Mejía-Domínguez NR, Juárez-Vega G, Bousfield GR, Ulloa-Aguirre A. In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity. J Endocr Soc 2020;4:bvaa019. [PMID: 32342021 DOI: 10.1210/jendso/bvaa019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
16 Khalid E, Chang JP. β-Arrestin-dependent signaling in GnRH control of hormone secretion from goldfish gonadotrophs and somatotrophs. General and Comparative Endocrinology 2020;287:113340. [DOI: 10.1016/j.ygcen.2019.113340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Tyurin-Kuzmin PA, Kalinina NI, Kulebyakin KY, Balatskiy AV, Sysoeva VY, Tkachuk VA. Angiotensin receptor subtypes regulate adipose tissue renewal and remodelling. FEBS J 2020;287:1076-87. [PMID: 31899581 DOI: 10.1111/febs.15200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
18 Smith TJ, Janssen JAMJL. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy. Endocr Rev 2019;40:236-67. [PMID: 30215690 DOI: 10.1210/er.2018-00066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 57] [Article Influence: 12.7] [Reference Citation Analysis]
19 Landomiel F, De Pascali F, Raynaud P, Jean-Alphonse F, Yvinec R, Pellissier LP, Bozon V, Bruneau G, Crépieux P, Poupon A, Reiter E. Biased Signaling and Allosteric Modulation at the FSHR. Front Endocrinol (Lausanne) 2019;10:148. [PMID: 30930853 DOI: 10.3389/fendo.2019.00148] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
20 Ulloa-Aguirre A, Reiter E, Crépieux P. FSH Receptor Signaling: Complexity of Interactions and Signal Diversity. Endocrinology 2018;159:3020-35. [PMID: 29982321 DOI: 10.1210/en.2018-00452] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 11.7] [Reference Citation Analysis]
21 Shimada I, Ueda T, Kofuku Y, Eddy MT, Wüthrich K. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat Rev Drug Discov 2019;18:59-82. [PMID: 30410121 DOI: 10.1038/nrd.2018.180] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 24.3] [Reference Citation Analysis]
22 Sayers N, Hanyaloglu AC. Intracellular Follicle-Stimulating Hormone Receptor Trafficking and Signaling. Front Endocrinol (Lausanne) 2018;9:653. [PMID: 30450081 DOI: 10.3389/fendo.2018.00653] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
23 Yvinec R, Crépieux P, Reiter E, Poupon A, Clément F. Advances in computational modeling approaches of pituitary gonadotropin signaling. Expert Opinion on Drug Discovery 2018;13:799-813. [DOI: 10.1080/17460441.2018.1501025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Hanyaloglu AC, Grammatopoulos DK. Pleiotropic GPCR signaling in health and disease. Molecular and Cellular Endocrinology 2017;449:1-2. [DOI: 10.1016/j.mce.2017.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Ranjan R, Dwivedi H, Baidya M, Kumar M, Shukla AK. Novel Structural Insights into GPCR-β-Arrestin Interaction and Signaling. Trends Cell Biol 2017;27:851-62. [PMID: 28651823 DOI: 10.1016/j.tcb.2017.05.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 12.4] [Reference Citation Analysis]
26 Kuwasako K, Kitamura K, Nagata S, Sekiguchi T, Danfeng J, Murakami M, Hattori Y, Kato J. β-arrestins negatively control human adrenomedullin type 1-receptor internalization. Biochem Biophys Res Commun 2017;487:438-43. [PMID: 28427767 DOI: 10.1016/j.bbrc.2017.04.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]